Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
Express Scripts
Boehringer Ingelheim

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087702

« Back to Dashboard
NDA 087702 describes DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Fresenius Kabi Usa, Intl Medication, Teva Parenteral, Luitpold, Wyeth Ayerst, Bel Mar, Akorn, Dell Labs, Lyphomed, Bausch And Lomb, Sola Barnes Hind, Sandoz Inc, and Aurobindo Pharma Ltd, and is included in twenty-eight NDAs. It is available from twenty suppliers. Additional details are available on the DEXAMETHASONE SODIUM PHOSPHATE profile page.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Summary for NDA: 087702

Pharmacology for NDA: 087702

Suppliers and Packaging for NDA: 087702

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
dexamethasone sodium phosphate
INJECTABLE;INJECTION 087702 ANDA West-Ward Pharmaceuticals Corp. 0641-0367 0641-0367-25 25 VIAL in 1 CARTON (0641-0367-25) > 1 mL in 1 VIAL (0641-0367-21)
dexamethasone sodium phosphate
INJECTABLE;INJECTION 087702 ANDA Terrain Pharmaceuticals 53225-3660 53225-3660-1 1 mL in 1 VIAL (53225-3660-1)

Summary for product number 001

Approval Date:Sep 7, 1982TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus